Preventive effects of danazol on endometrial carcinogenesis in mice
article
OA: closed
CC0
⤵ 5 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study investigated the preventive effects of danazol on endometrial carcinogenesis in mice and found it reduced tumor development.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (22)
- Clinical effects of danazol on endometrial hyperplasia in menopausal and postmenopausal women via openalex
- Clinical Studies with an Antigonadotropin-Danazol via openalex
- Danazol: An antigonadotropic agent in the treatment of pelvic endometriosis via openalex
- Effects of an androgenic derivative on the development of chemically-induced mammary carcinogenesis in the rat. via openalex
- Endocrine changes in postmenopausal women after high-dose danazol therapy. via openalex
- Preliminary report on the use of danazol in the treatment of endometrial adenomatous hyperplasia via openalex
- The effectiveness of danazol therapy in postmenopausal women affected by endometrial hyperplasia. via openalex
- doi:10.1242/dev.99.4.449 via openalex
- W3142797338 via openalex
- W6716593565 via openalex
- W6792183410 via openalex
- doi:10.1111/j.1349-7006.1995.tb02460.x via openalex
- doi:10.1111/j.1349-7006.1993.tb00183.x via openalex
- doi:10.1016/0378-1119(90)90087-8 via openalex
- doi:10.1016/0304-3835(95)03979-7 via openalex
- doi:10.1016/0092-8674(83)90306-9 via openalex
- doi:10.1210/mend-2-9-816 via openalex
- doi:10.1210/mend-4-7-1041 via openalex
- doi:10.1007/978-3-642-85014-1 via openalex
- doi:10.1111/j.1349-7006.1998.tb03290.x via openalex
- doi:10.1111/j.1349-7006.1999.tb00807.x via openalex
- doi:10.1038/334629a0 via openalex
Cited by (5)
- Androgen Signaling in Uterine Diseases: New Insights and New Targets 2022
- MicroRNA-Regulated Pathways Associated with Endometriosis 2008
- Endometriosis: harmful survival of an ectopic tissue 2006
- FOXO1 and c-jun transcription factors mRNA are modulated in endometriosis 2004
- Phase II trial of danazol in advanced, recurrent, or persistent endometrial cancer: a Gynecologic Oncology Group study 2003
Source provenance
- openalex
- last seen: 2026-05-11T06:00:05.006021+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK